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Evidence from several sources suggests that the
presence of vulvar condylomata acuminata
predisposes to the development of carcinoma at
that site [Buscema et al., 1980; Friedrich et al.,
1980; Kovi et al., 1974; Rastkar et al., 1982; and
Woodruff et al., 1980]. The two lesions are often
found in the same patient; from 7% to 26% of
women with vulvar squamous tumours are found to
have one or more condylomata. These observations,
however, only represent case series which may not
be representative of any defined population.
Though it has not been determined that this
coexistence is beyond that which could be expected
on the basis of chance, the fact that the lesions
have been observed on a microscopic level to merge
into one another [Crum et al., 1982] suggests more
than mere coincidence. Indeed, some condylomata
have been observed to undergo malignant change
over time [Kovi et al., 1974].
The purpose of the present study was to quantify
the degree to which condylomata acuminata occur
more commonly in women with vulvar squamous
neoplasms than they do in other women.
The Cancer Surveillance System, a population-
based cancer registry serving 13 western
Washington counties, was used to identify female
residents with a new diagnosis of vulvar cancer
(both in situ and invasive) during the period
January 1974 through December 1981. It is
estimated that at least 98% of cases of cancer of all
sites that occur among the approximately 1.4
million residents of this area are reported to the
registry. Hospital tumour registries or CSS registry
staff are uniformly trained to abstract medical
records of patients with cancer. Descriptions of the
preoperative physical exam and the surgical and
microscopic findings are included to facilitate the
coding of the tumour's morphology and stage.
Thus, even though the presence of conditions other
than the tumour (such as condylomata) are not
systematically identified in the registry, there is
often enough information found in the record
abstract to determine whether or not they are
present. In this study the tumour registry's abstract
of all patients with vulvar cancers were reviewed for
mention of "condyloma" or "genital warts."
To provide a basis for comparison, we separated
the cases with vulvar tumours into squamous and
"nonsquamous" groups. Tumours in the latter
category, which include melanoma, basal cell
carcinoma, fibrosarcoma, and Paget's disease, are
sufficienctly different from squamous lesions in
terms of morphology and histology to make
unlikely the possibility that they share common
aetiologies. Thus, the group of women with these
other tumours served as "controls", i.e. women
without squamous tumours who underwent the
same examination for the presence of genital warts
as did the cases with squamous tumours. The
statistical significance of comparisons between
squamous and nonsquamous cases was assessed
using the method of Mantel & Haenszel (1959).
During the 8-year study period, 362 cases of
squamous carcinoma of the vulva occurred in the
registry area, 221 of which were in situ. In addition,
there were 49 nonsquamous carcinomas of the
vulva. Four cases were excluded because their
histologic type was not indicated.
Of women with squamous tumours, 16.6% were
reported to have had condylomata. The percentage
was higher at younger ages, but differed little
between the in situ and invasive groups after
adjusting for age (Table I). No such lesions were
reported in any of the 49 women with
nonsquamous tumours. The age-adjusted difference
in the frequency of condyloma between squamous
and nonsquamous cases was unlikely to have been
due to chance (P<0.01) for either in situ or
invasive cases. Condylomata were observed in
women with vulvar squamous cancers throughout
the duration of the study, and in residents of both
urban and rural counties (Table II).
In attempting to determine whether the
prevalence of vulvar warts is uncommonly high
among women with vulvar squamous tumours, our
study has two strengths not present in prior studies
of this question. First, the cases are nearly all those
arising in a defined population, eliminating the
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Table I Proportion of women with vulvar neoplasms who had
histological type and age
coexisting condyloma, by
Histologic type
Squamous, in situ Squamous, invasive Nonsquamousa
Age Total With condyloma Total With condyloma Total With condyloma
(years) number Number Percent number Number Percent number Number Percent
.29 37 15 40.5 5 1 20.0 5 0 0
30-39 44 15 34.1 8 1 12.5 2 0 0
40-49 41 6 14.6 11 1 9.1 2 0 0
50-59 35 2 5.7 21 5 23.8 8 0 0
60-69 42 2 4.8 27 2 7.4 9 0 0
>70 22 3 13.6 69 7 10.1 23 0 0
Total 221 43 12.9b 141 17 12.1 49 0 0
aMelanoma, basal cell carcinoma, fibrosarcoma, Paget's disease.
bAdjusted to the age distribution of women with invasive squamous tumours.
Table II Proportion of women with squamous vulvar neoplasms who had
coexisting condyloma, by year of diagnosis and county of residence
Stage ofdisease
In situ Invasive
Total With condyloma Total With condyloma
number Number Percent number Number Percent
Year ofdiagnosis
1974-75 40 1 2.5 25 4 16.0
1976-77 54 10 18.5 36 2 5.6
1978-79 64 14 21.9 43 5 11.6
1980-81 63 18 28.6 37 6 16.2
County ofresidence
Urbana 182 37 20.3 102 14 13.7
Rural 39 6 15.4 39 3 7.7
aThree metropolitan counties with 75% of the total population.
possibility that some sort of selection process has
led to an anomalously high proportion of women
with warts. Second, for purposes of comparison, we
have identified the prevalence of vulvar warts in a
group of women who did not have squamous
tumours.
An important limitation of our study relates to
the fact that there was neither a standardized
review of the accuracy of the diagnoses of the
vulvar neoplasms, nor a standardized examination
of cases and "controls" for the presence of vulvar
warts. In order for our findings to have validity it is
necessary to assume that, if vulvar warts are
present in a woman with a vulvar neoplasm, their
presence will be noted in the medical record and
abstracted by the tumour registrar with the same
diligence regardless of the neoplasm's histologic
type. We believe this to be a reasonable
assumption. Since a spectrum of atypia can occur
in condylomata that can resemble squamous
carcinoma in situ [Crum et al., 1982], the failure to
eliminate cases that were not truly malignant could
have led to an artificially strong association.
However, the finding of an elevated frequency of
condylomata in women with invasive as well as in
situ vulvar squamous tumours, as compared to
women with nonsquamous tumours, argues that the
association is real. Furthermore, the increased
frequency of warts was found in patients diagnosed
throughout the thirteen county area, not just in
those residing in urban areas where the quality of
pathologic diagnoses might be better.
The strong association between condylomata
acuminata and vulvar squamous tumours is
evidence in support of a causal relationship between
the two. Even so, it does not imply a high absoluteCONDYLOMA AND VULVAR CANCER 535
risk of vulvar squamous tumours for the woman
with one or more condylomata. The combined
incidence of vulvar in situ and invasive squamous
tumours - less than 4 per 100,000 women per year
[SEER, 1973-77] - gives rise to fewer than 4000
new cases in the United States annually, very much
smaller than the number of women who develop
condylomata each year in that country [MMWR,
1983]. The particular aspects of the condylomata,
their treatment, or the woman that predispose to
malignant change are poorly understood. The
elucidation of these ought to be a high priority for
subsequent research in this field.
We thank Anne Peterson for her assistance in the
preparation of this manuscript. Availability of data from
the Cancer Surveillance System, and the assistance of its
staff, are greatly appreciated.
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